White House to announce new drug pricing deals with biotechs, Bloomberg News reportsReuters • 08/26/26
PFE vs BMY: Which Large Oncology Drugmaker Is a Better Stock Now?Zacks Investment Research • 08/25/26
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend YieldsBenzinga • 08/25/26
Yield Hunters Are Swarming This 6.3%-Dividend Stock—And Big-League Hedge Funds are Quietly Buying the Dip24/7 Wall Street • 08/20/26
Billionaire Bruce Berkowitz Reveals 76% Of Fairholme Capital Is in Just 1 Stock24/7 Wall Street • 08/18/26
Warren Buffett and Greg Abel Keep Overlooking This Stock -- but It's One of the Most Berkshire-Ready Picks on the MarketThe Motley Fool • 08/18/26
European Regulator Validates Pfizer and Valneva's Lyme Disease Vaccine ApplicationBenzinga • 08/14/26
Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get moneyFast Company • 08/14/26
Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines AgencyBusiness Wire • 08/14/26
Will Pfizer's Non-COVID Portfolio Drive Its Next Phase of Growth?Zacks Investment Research • 08/12/26
The S&P 500 Yield Is the Lowest in History: 5 Members of the Legacy Index Yield 6% or More24/7 Wall Street • 08/12/26